Share This Page
Drug Price Trends for HM ANTACID
✉ Email this page to a colleague

Average Pharmacy Cost for HM ANTACID
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
HM ANTACID EX-STR 750 MG CHEW | 62011-0397-01 | 0.03208 | EACH | 2025-01-22 |
HM ANTACID ANTI-GAS SUSPENSION | 62011-0149-01 | 0.01142 | ML | 2025-01-22 |
HM ANTACID-ANTIGAS SUSPENSION | 62011-0292-01 | 0.01055 | ML | 2025-01-22 |
HM ANTACID 500 MG CHEW TABLET | 62011-0482-01 | 0.01669 | EACH | 2025-01-22 |
HM ANTACID ANTI-GAS SUSPENSION | 62011-0149-01 | 0.01160 | ML | 2024-12-18 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Global Antacids Market Analysis and Projections
Executive Summary
The global antacids market is experiencing significant growth driven by increasing prevalence of gastrointestinal issues such as heartburn, gastroesophageal reflux disease (GERD), and other digestive disorders. Here’s a comprehensive overview of the market trends, projections, and key factors influencing the antacids market.
Market Size and Growth Projections
- The global antacids market was valued at approximately USD 6.6 billion to USD 7 billion in 2022, depending on the source[3][4][5].
- By 2033, the market is expected to reach USD 11.19 billion to USD 22 billion, with a compound annual growth rate (CAGR) ranging from 3.7% to 4.9% during the forecast period[1][3][5].
Segmentation and Distribution Channels
- The market is segmented by drug class, formulation type, and distribution channels. Proton pump inhibitors (PPIs) are leading the market with a significant share, around 25.8% in 2022[5].
- Antacids are available in various forms such as tablets, powders, and liquids, with tablets accounting for about 50% of the global market in 2023[1].
- Distribution channels include retail pharmacies, online pharmacies, and other outlets. Retail pharmacies currently dominate the market, but online pharmacies are expected to grow at the highest CAGR due to the convenience and rising popularity of online shopping[1][4].
Regional Analysis
- North America, particularly the United States, holds a significant market share, around 28.1%, due to high disposable income, an aging population, and a well-established healthcare system[5].
- The Asia Pacific region is expected to be the fastest-growing market, driven by factors such as rising disposable income, consumer awareness, and the presence of major players like Takeda Pharmaceutical Company Ltd., Sun Pharmaceutical Industries Ltd., and Dr Reddy's Laboratories Ltd.[4].
Driving Factors
- The increasing prevalence of heartburn, GERD, and other gastrointestinal disorders is a major driver of the market. For instance, approximately 784 million individuals were affected by GERD globally in 2019[3][4].
- Changing dietary habits and the trend towards self-medication are also contributing to the market growth[3][5].
Challenges and Side Effects
- Despite the growth, the market faces challenges such as concerns over side effects. Antacids can cause milk-alkali syndrome, dose-dependent rebound hyperacidity, and other issues like aluminum poisoning, constipation, and osteomalacia when containing aluminum hydroxide[5].
- These side effects may slow the market expansion and necessitate the development of new, safer antacid formulations.
Key Players and Market Strategies
- Major players in the antacids market include Johnson and Johnson, Sanofi S.A., Bayer AG, and Sun Pharmaceuticals Ltd. These companies are investing in drug development and discovery to expand their market share[5].
- To strategically expand, companies need to conduct meticulous market research to understand consumer preferences and develop customized products that meet evolving demands. Innovative marketing strategies, including storytelling and focused advertising, are crucial for brand loyalty and differentiation[4].
Online Pharmacy Segment Growth
- The online pharmacy segment is anticipated to grow significantly due to the expanding e-commerce sector, same-day delivery facilities, and special discounts. High penetration of smartphones and improvements in telecom services are also driving antacid sales through online pharmacies[1][4].
Consumer Trends and Preferences
- Consumers are increasingly opting for over-the-counter (OTC) medications due to their ease of access and availability. This trend towards self-medication is driving the demand for antacids[5].
- Retail pharmacies offering generic and OTC medications, special discounts, and 24x7 home delivery services are also contributing to the market growth[4].
Statistical Highlights
- In 2019, approximately 783.95 million people were diagnosed with GERD globally, according to a study by the National Institutes of Health (NIH)[3].
- In the United States, there were 8 million visits to emergency departments for digestive issues as the primary diagnosis in 2019, as reported by the Centers for Disease Control and Prevention[5].
Key Takeaways
- The global antacids market is projected to grow significantly due to the increasing prevalence of gastrointestinal disorders.
- Online pharmacies are expected to see rapid growth due to convenience and technological advancements.
- Major players are focusing on developing new, safer antacid formulations to address side effect concerns.
- Regional markets, especially in the Asia Pacific, are expected to show high growth rates.
Frequently Asked Questions (FAQs)
1. What is the current market size of the global antacids market? The global antacids market was valued at approximately USD 6.6 billion to USD 7 billion in 2022.
2. What is the projected growth rate of the antacids market from 2023 to 2033? The market is expected to grow at a CAGR ranging from 3.7% to 4.9% during the forecast period.
3. Which region is expected to be the fastest-growing market for antacids? The Asia Pacific region is anticipated to be the fastest-growing market due to rising disposable income, consumer awareness, and the presence of significant players.
4. What are the major drivers of the antacids market? The increasing prevalence of heartburn, GERD, and other gastrointestinal disorders, along with changing dietary habits and the trend towards self-medication, are major drivers.
5. Which distribution channel is expected to grow the fastest in the antacids market? The online pharmacy segment is expected to grow the fastest due to the convenience of online shopping, same-day delivery facilities, and special discounts.
Cited Sources:
- Fact.MR - Antacids Market Size, Share, Demand & Growth Analysis, 2033
- The Brainy Insights - Antacids Market Size & Share Analysis Report, 2032
- Grand View Research - Antacids Market Size, Share & Growth Analysis Report, 2030
- Towards Healthcare - Antacids Market Size, Trends & 3.30% CAGR Growth by 2034
- Future Market Insights - Antacids Market Size, Share, Trends & Forecast by 2033
More… ↓